Cargando…

The Predictive Value of PITX2 DNA Methylation for High-Risk Breast Cancer Therapy: Current Guidelines, Medical Needs, and Challenges

High-risk breast cancer comprises distinct tumor entities such as triple-negative breast cancer (TNBC) which is characterized by lack of estrogen (ER) and progesterone (PR) and the HER2 receptor and breast malignancies which have spread to more than three lymph nodes. For such patients, current (int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aubele, Michaela, Schmitt, Manfred, Napieralski, Rudolf, Paepke, Stefan, Ettl, Johannes, Absmaier, Magdalena, Magdolen, Viktor, Martens, John, Foekens, John A., Wilhelm, Olaf G., Kiechle, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613359/ https://www.ncbi.nlm.nih.gov/pubmed/29138528 http://dx.doi.org/10.1155/2017/4934608

Ejemplares similares

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
por: Absmaier, Magdalena, et al.
Publicado: (2018)

Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
por: Schricker, Gabriele, et al.
Publicado: (2018)

Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
por: Falkenberg, Natalie, et al.
Publicado: (2015)

Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients’ needs
por: Schürger, Nikolas, et al.
Publicado: (2018)

First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer
por: Ettl, Johannes, et al.
Publicado: (2020)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy
por: Drozdoff, Loisa, et al.
Publicado: (2018)

Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1
por: Ettl, Johannes, et al.
Publicado: (2017)

Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy
por: Schmidt, Georg, et al.
Publicado: (2020)

Lifestyle modifications after the diagnosis of gynecological cancer
por: Paepke, Daniela, et al.
Publicado: (2021)

Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology
por: Drozdoff, Loisa, et al.
Publicado: (2019)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
por: Liu, Yueyang, et al.
Publicado: (2022)

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
por: Geng, Xiaocong, et al.
Publicado: (2017)

Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells
por: Schmitt, Manfred, et al.
Publicado: (2009)

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2019)

Pitx2 in Embryonic and Adult Myogenesis
por: Hernandez-Torres, Francisco, et al.
Publicado: (2017)

Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study
por: Gross, Eva, et al.
Publicado: (2016)

Downregulation of Serine Protease HTRA1 Is Associated with Poor Survival in Breast Cancer
por: Lehner, Anna, et al.
Publicado: (2013)

PITX1 plays essential functions in cancer
por: Zhao, Jingpu, et al.
Publicado: (2023)

Genetic association and differential expression of PITX2 with acute appendicitis
por: Orlova, Ekaterina, et al.
Publicado: (2018)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer
por: Seitz, Stefanie, et al.
Publicado: (2022)

Transgenic Insights Linking Pitx2 and Atrial Arrhythmias
por: Franco, Diego, et al.
Publicado: (2012)

Multiple Roles of Pitx2 in Cardiac Development and Disease
por: Franco, Diego, et al.
Publicado: (2017)

Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany
por: Grimm, Donata, et al.
Publicado: (2020)

A PITX2 splice-site mutation in a family with Axenfeld-Rieger syndrome leads to decreased expression of nuclear PITX2 protein
por: Zhang, Feng, et al.
Publicado: (2021)

A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer
por: Borm, Kai J., et al.
Publicado: (2021)

A novel PITX2 mutation causing iris hypoplasia
por: Kimura, Masashi, et al.
Publicado: (2014)

Decoding the PITX2-controlled genetic network in atrial fibrillation
por: Steimle, Jeffrey D., et al.
Publicado: (2022)

Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors
por: Borm, Kai J., et al.
Publicado: (2018)

Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer
por: Huber, Michaela C., et al.
Publicado: (2016)

The role of Pitx2 and Pitx3 in muscle stem cells gives new insights into P38α MAP kinase and redox regulation of muscle regeneration
por: L'honoré, Aurore, et al.
Publicado: (2018)

Glaucoma spectrum and age-related prevalence of individuals with FOXC1 and PITX2 variants
por: Souzeau, Emmanuelle, et al.
Publicado: (2017)

Surgical Studies of Reconstructive Breast Surgery – An Overview of the Topics at the 2019 Annual Meeting of the Working Group for Reconstructive Surgery in Oncology-Gynecology
por: Paepke, Stefan, et al.
Publicado: (2019)

Iyengar-Yoga Compared to Exercise as a Therapeutic Intervention during (Neo)adjuvant Therapy in Women with Stage I–III Breast Cancer: Health-Related Quality of Life, Mindfulness, Spirituality, Life Satisfaction, and Cancer-Related Fatigue
por: Lötzke, Désirée, et al.
Publicado: (2016)

PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia
por: Mudie, Sharon, et al.
Publicado: (2015)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)

PITX2 gain-of-function induced defects in mouse forelimb development
por: Holmberg, Johan, et al.
Publicado: (2008)

Functional analysis of human mutations in homeodomain transcription factor PITX3
por: Sakazume, Satoru, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nsalqmhdjsl5lrjh5ir4rbbmqr